Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
$7.31M Sell
42,467
-42,252
-50% -$6.87M 0.32% 92
2017
Q1
$13.9M Sell
84,719
-11,919
-12% -$1.98M 0.68% 37
2016
Q4
$14.1M Sell
96,638
-10,405
-10% -$1.57M 1.14% 16
2016
Q3
$17.9M Buy
107,043
+33,364
+45% +$5.64M 1.06% 8
2016
Q2
$11.2M Buy
73,679
+68,610
+1,354% +$10.7M 0.65% 31
2016
Q1
$760K Sell
5,069
-110,462
-96% -$16.4M 0.05% 349
2015
Q4
$18.8M Buy
115,531
+36,225
+46% +$5.69M 1.29% 3
2015
Q3
$11M Buy
79,306
+1,692
+2% +$267K 0.66% 18
2015
Q2
$11.9M Sell
77,614
-12,770
-14% -$2.05M 0.67% 17
2015
Q1
$14.4M Buy
90,384
+26,065
+41% +$4.11M 0.88% 9
2014
Q4
$10.2M Buy
+64,319
New +$10M 0.84% 15
2014
Q3
Sell
-66,618
Closed -$7.89M 778
2014
Q2
$7.89M Buy
66,618
+51,090
+329% +$5.91M 0.65% 31
2014
Q1
$1.92M Sell
15,528
-29,786
-66% -$3.61M 0.34% 79
2013
Q4
$5.17M Buy
45,314
+4,369
+11% +$497K 0.67% 27
2013
Q3
$4.58M Buy
40,945
+15,127
+59% +$1.64M 0.85% 18
2013
Q2
$2.55M Buy
+25,818
New +$2.68M 0.38% 52

Other funds holding AMGN

Airain Ltd's AMGN Position: Q2 2017 in Review

Airain Ltd reduced its Amgen (AMGN) stake by 50% in Q2 2017, selling an estimated $6.87M and leaving 42,467 shares worth $7.31M. The position accounts for 0.32% of the portfolio, ranked #92.

Airain Ltd first reported a position in AMGN in Q2 2013 and has held it in 16 quarters since. The position peaked at $18.8M in Q4 2015. 1,595 funds tracked by Wall St. Rank hold AMGN as of Q2 2017.

  • Airain Ltd held 42,467 shares of Amgen worth $7.31M as of Q2 2017.
  • Airain Ltd sold 42,252 Amgen shares in Q2 2017, an estimated $6.87M.
  • Amgen made up 0.32% of Airain Ltd's portfolio in Q2 2017, its #92 holding.
  • Airain Ltd first reported a position in Amgen in Q2 2013 and has held it in 16 quarters since.
  • Airain Ltd's Amgen position peaked at $18.8M in Q4 2015.
  • 1,595 funds tracked by Wall St. Rank held Amgen as of Q2 2017.

Based on Airain Ltd's 13F filing for Q2 2017, filed 8 Aug 2017.